Wu Jinzi Jason
SEC CIK 1858174 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SGMT | Sagimet Biosciences Inc. | Dir | 1.65M | — | — | 1 | 2023-07-18 | 2023-07-18 |
Most active insiders at SGMT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Kemble George | Executive COB, Dir | — | $4.22M |
| 2 | Happel David | Pres, CEO, Dir | — | $561.9K |
| 3 | Rozek Elizabeth | Chief Legal, Admin. Off | — | $95.9K |
| 4 | Martins Eduardo Bruno | Chief Medical Off | — | $19.5K |
| 5 | Chauche Thierry | CFO | — | $7,032 |
Wu Jinzi Jason made no open-market trades at SGMT in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-20 | 2023-07-18 | SGMT | Sagimet Biosciences Inc. | Wu Jinzi Jason | Dir | C - Cnv Deriv | — | +1.65M | 1.65M | New | — |
Purchase Sale Sale after option exercise All abbreviations